City

Portland (1)

Seattle (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

OHSU Knight Cancer Institute (1)

University of Washington (1)

Collaborator

Genentech, Inc. (1)

GlaxoSmithKline (1)

Oregon Health and Science University (1)

Study Documents

Intervention Type

biological (2)

drug (2)

other (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

unresectable ovarian carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting

Anatomic Stage III Breast Cancer AJCC v8
+14 more

Biopsy
+25 more

Portland, Oregon

OHSU Knight Cancer Institute

Jul 12, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting

Anatomic Stage III Breast Cancer AJCC v8
+51 more

Dostarlimab
Niraparib

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Mar 15, 2022